Skip to main content
Fig. 4 | Nutrition Journal

Fig. 4

From: Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States

Fig. 4

Subgroup analysis of the association between sarcopenia and hepatic fibrosis in patients with MASLD in the US cohort. A association between sarcopenia and significant fibrosis; B association between sarcopenia and advanced fibrosis; C association between sarcopenia and cirrhosis. Adjusted variables: gender, age, smoke, alcohol, physical activity, diabetes mellitus, hypertension. The model was not adjusted for the stratification variables themselves in the corresponding stratification analysis. Abbreviations: MASLD, Metabolic dysfunction-associated steatotic liver disease; OR: odds ratio; CI: confidence interval

Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us